These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. The history of the use of sulphasalazine in rheumatology. Amos RS Br J Rheumatol; 1995 Nov; 34 Suppl 2():2-6. PubMed ID: 8535643 [TBL] [Abstract][Full Text] [Related]
5. [Sulphasalazine: a promising drug in rheumatology]. Nasonov EL Klin Med (Mosk); 1997; 75(6):39-44. PubMed ID: 9273399 [No Abstract] [Full Text] [Related]
6. The antirheumatic agents sulphasalazine and methotrexate share an anti-inflammatory mechanism. Cronstein BN Br J Rheumatol; 1995 Nov; 34 Suppl 2():30-2. PubMed ID: 8535646 [TBL] [Abstract][Full Text] [Related]
7. Sulphasalazine, sulphapyridine or 5-aminosalicylic acid--which is the active moiety in rheumatoid arthritis? Bird HA Br J Rheumatol; 1995 Nov; 34 Suppl 2():16-9. PubMed ID: 8535642 [TBL] [Abstract][Full Text] [Related]
8. [Significance of intestinal inflammation in the pathogenesis of spondylarthropathies]. Mielants H; Veys EM Verh K Acad Geneeskd Belg; 1996; 58(2):93-116. PubMed ID: 8768479 [TBL] [Abstract][Full Text] [Related]
9. Differential efficacy of tumor necrosis factor inhibition in the management of inflammatory eye disease and associated rheumatic disease. Smith JR; Levinson RD; Holland GN; Jabs DA; Robinson MR; Whitcup SM; Rosenbaum JT Arthritis Rheum; 2001 Jun; 45(3):252-7. PubMed ID: 11409666 [TBL] [Abstract][Full Text] [Related]
10. Sulphasalazine in arthritis--an old drug rediscovered. Taggart AJ Clin Rheumatol; 1987 Sep; 6(3):378-83. PubMed ID: 2894913 [TBL] [Abstract][Full Text] [Related]
11. [Sulfasalazine as an antirheumatic agent; a review of the literature]. Zanen P Ned Tijdschr Geneeskd; 1988 Jan; 132(5):196-9. PubMed ID: 2893300 [No Abstract] [Full Text] [Related]
12. The use of sulphasalazine as a disease modifying antirheumatic drug. Porter DR; Capell HA Baillieres Clin Rheumatol; 1990 Dec; 4(3):535-51. PubMed ID: 1982707 [TBL] [Abstract][Full Text] [Related]
13. Possible mechanisms of action of antimalarials in rheumatic disease. Cutler DJ Agents Actions Suppl; 1993; 44():139-43. PubMed ID: 8372722 [TBL] [Abstract][Full Text] [Related]
15. Rheumatoid arthritis: a risk factor for sulphasalazine toxicity? A meta-analysis. Wijnands MJ; Van 'T Hof MA; Van De Putte LB; Van Riel PL Br J Rheumatol; 1993 Apr; 32(4):313-8. PubMed ID: 8096419 [TBL] [Abstract][Full Text] [Related]
16. Pharmacogenetics in the rheumatic diseases. Cronstein BN Bull NYU Hosp Jt Dis; 2006; 64(1-2):16-9. PubMed ID: 17121484 [TBL] [Abstract][Full Text] [Related]
17. Etanercept: new preparation. Useful after methotrexate failure in inflammatory rheumatism. Prescrire Int; 2003 Aug; 12(66):127-32. PubMed ID: 12906020 [TBL] [Abstract][Full Text] [Related]
18. Combination of sulphasalazine and methotrexate in the management of rheumatoid arthritis--view based on personal clinical experience. Shiroky JB Br J Rheumatol; 1995 Nov; 34 Suppl 2():109-12. PubMed ID: 8535641 [TBL] [Abstract][Full Text] [Related]
19. Leflunomide for rheumatoid arthritis. Drug Ther Bull; 2000 Jul; 38(7):52-4. PubMed ID: 11027115 [TBL] [Abstract][Full Text] [Related]
20. An update on methotrexate. Braun J; Rau R Curr Opin Rheumatol; 2009 May; 21(3):216-23. PubMed ID: 19373092 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]